Taken together, these results suggest that hyperlipidemia, which is common in obesity and metabolic syndrome, may be a confounding factor, and that the absence of CCL2 may be as metabolically deleterious as overexpression of CCL2 in certain conditions. This evidence concerns the gene CCL2 and Obesity.